This month's episode of the JNM Podcast takes the discussion of Pb-212 worldwide! Learn more from Jane Sosabowski, David Bauer, and Nick Fletcher with host and moderator, Ken Herrmann. Full episode: youtube.com/watch?v=9PA-JS… #nuclearmedicine #medicalresearch

JNM’s #SNMMI24 Arena Session will cover topics that matter to you: scientific misconduct and plagiarism, AI-written articles, impact factor pandering, and more. Join us June 10 from 12:45-2:00 pm. ow.ly/bZmg50RAQTU

Irène Buvat Satoshi Minoshima Johannes Czernin Marcelo Di Carli

More than 10,000 papers were retracted in 2023 & 50 percent of study results were not reproducible. What's happening? Find out at the JNM Arena Session at #SNMMI24 on Monday, June 10 from 12:45-2:00 pm. snmmi.org/am

Irène Buvat Satoshi Minoshima Johannes Czernin Marcelo Di Carli

Ever wonder why JNM and other #NuclearMedicine journals publish the articles they do? Find out at the JNM Arena Session at #SNMMI24 on Monday, June 10 from 12:45-2:00 pm. snmmi.org/am

Irène Buvat Satoshi Minoshima Johannes Czernin Marcelo Di Carli

The landscape of #NuclearMedicine in China and its progress on #theranostics : ow.ly/r97b50REnXL.

Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future. ow.ly/uZyu50REnSQ

#NuclearMedicine #Melanoma #PETscan

Hear presentations from the authors of JNM Manuscripts of the Year at the JNM Arena Session at the Annual Meeting, Monday, June 10 from 12:45-2:00 pm. snmmi.org/am

#SNMMI24 #NuclearMedicine Irène Buvat Satoshi Minoshima Johannes Czernin Marcelo Di Carli

Advancing Global Nuclear Medicine: The Role and Contributions of China. ow.ly/63nT50REnMW

#NuclearMedicine #China #MolecularImaging @ProfKHermmann Weibo Cai

Mark your calendar! Join JNM editors at the SNMMI Annual Meeting on Monday, June 10, from 12:45-2:00 pm for an Arena Session titled “Publishing Multiverse: Quality, Plagiarism, and AI.” snmmi.org/am

#SNMMI24 Irène Buvat Satoshi Minoshima Johannes Czernin Marcelo Di Carli

Check out JNM’s new supplement: Advancing Global Nuclear Medicine: The Role and Contributions of China. ow.ly/kfLW50Rxq5N

#NuclearMedicine #China #MolecularImaging @ProfKHermmann Weibo Cai

JNM Illustrated Post: ¹⁷⁷Lu-PSMA -617 in a patient with metastatic castration-resistant #ProstateCancer and status after bilateral nephrectomy. ow.ly/TT1a50Rn4Au

#NuclearMedicine #RPTherapy

In patients treated with ¹⁷⁷Lu-DOTATATE for GEP-NETs, tumor and healthy organ dosimetry can predict survival and toxicities, influencing clinical management. ow.ly/YH2j50RmkUc

#NuclearMedicine #RPTherapy #NeuroendocrineTumors

p-aminohippuric acid is a promising alternative to amino acid coinfusion for renal protection during peptide receptor radiotherapy for #NeuroendocrineTumors . ow.ly/T9fz50RmkPr

#NuclearMedicine #RPTherapy Ken Herrmann

The HIT score is a simple clinically applicable PSMA PET/CT score that shows promising capability to predict patient outcomes with ¹⁷⁷Lu-PSMA therapy without requiring further quantification. ow.ly/ePnw50RmkGo

#NuclearMedicine #ProstateCancer Mina Swiha

Episode 2 of the JNM Podcast is out! Featuring Ken Herrmann, Henryk Barthel, Gil Rabinovici, and Victor Villemagne, the podcast focuses on the importance of amyloid and tau PET imaging in #dementia diagnosis. jnm.snmjournals.org/podcasts

#NuclearMedicine @ProKHerrmann

Detecting metastatic patterns of oligometastatic breast cancer: A comparative analysis of ¹⁸F-FDG PET/CT and conventional CT imaging. ow.ly/x1ra50Rk1c4

#NuclearMedicine #BreastCancer #PETscan @KaiBorm

Freek Beekman: Inventing His Own Career Path. ow.ly/mMvh50RaTrG

#MolecularImaging #NuclearMedicine

Can we measure programmed-death ligand 1 status in gastroesophageal cancer with PET? ow.ly/2K0K50R5LVU

#NuclearMedicine #GastricAdenocarcinoma #PETscan Memorial Sloan Kettering Cancer Center Sam Cytryn Yelena Y. Janjigian MD

Retreatment with ¹⁷⁷Lu-DOTATATE after progression is well tolerated and offers disease control in patients with progressive NETs after initial treatment. ow.ly/A3Yc50R5LTz

#NuclearMedicine #RPTherapy #NETcancer

The current and future roles of precision oncology in advanced breast cancer: ow.ly/CmtU50QUp4H

#NuclearMedicine #PrecisionOncology #BreastCancer Heather Jacene